Celtarys Research

Did you know that Celtarys Research is participating in the #EFMC-ISMC 2024 🙂 ? During the event, our CSO, Maria Majellaro, will present on September 4th, the latest updates in her talk: 'Revolutionizing Cancer Treatment: A Game-Changing Technology for Immune Checkpoints Targeting and PROTACs Development.' At the same time, our BDD Alessandro S., will discuss with researchers about the potential applications of Celtarys' advanced linkerology in the area of drug optimization and fluorescent probe generation. Feel free to contact them if you would like to explore potential collaboration opportunities 😁 .

Celtarys continues to disseminate its scientific contributions 🔬 . Last week, our colleague Lucía González Pico participated in the Symposium Jóvenes at CMU San Pablo in Madrid, organized by the Sociedad Española de Química Terapéutica (SEQT). After the oral presentation about the Celtarys GPCR Toolbox, along with José Manuel Bartolomé Nebreda (President of SEQT), Lucia participated in awarding the best presentations: - 🏆 Xavier Correia (Poster Presentation) - 🏆 Hugo Almeida (Flash Poster Presentation) - 🏆 Noelia Fernández Ceballos (Oral Communication) Thank you to everyone who participated in the event, and congratulations to the winners!

📣❤️🩹𝗔𝗱𝗿𝗲𝗻𝗲𝗿𝗴𝗶𝗰 𝗯𝗲𝘁𝗮-𝗯𝗹𝗼𝗰𝗸𝗲𝗿𝘀 are traditionally used to manage cardiovascular diseases, but nowadays are being investigated 🔬 for their potential benefits in treating various non-cardiovascular conditions, such as 𝗰𝗲𝗻𝘁𝗿𝗮𝗹 𝗻𝗲𝗿𝘃𝗼𝘂𝘀 𝘀𝘆𝘀𝘁𝗲𝗺 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀, 𝗱𝗶𝗮𝗯𝗲𝘁𝗲𝘀, 𝗰𝗮𝗻𝗰𝗲𝗿, and 𝗼𝗿𝗴𝗮𝗻 𝘁𝗼𝘅𝗶𝗰𝗶𝘁𝗶𝗲𝘀. 💥Don't miss the last update about management of 𝗔𝗱𝗿𝗲𝗻𝗲𝗿𝗴𝗶𝗰 𝗿𝗲𝗰𝗲𝗽𝘁𝗼𝗿𝘀 Click to read 📖 the article 👇 #𝗔𝗱𝗿𝗲𝗻𝗲𝗿𝗴𝗶𝗰𝗿𝗲𝗰𝗲𝗽𝘁𝗼𝗿𝘀 #Cardiovasculardiseases, #cancer, #diabetes, #probes, #CELT130 #CELT133 #tools

📣Did you know that 𝘁𝗵𝗲 𝗰𝗼𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁 𝘀𝘆𝘀𝘁𝗲𝗺 plays a crucial role in immune responses? 𝗖𝟱𝗮, a potent inflammatory mediator, interacts with the 𝗖𝟱𝗮 𝗿𝗲𝗰𝗲𝗽𝘁𝗼𝗿 𝟭 (C5aR1), influencing 𝗶𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 and potentially affecting 𝗻𝗲𝘂𝗿𝗼𝗽𝘀𝘆𝗰𝗵𝗶𝗮𝘁𝗿𝗶𝗰 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀.⁣ ⁣ 🔆𝗖𝗘𝗟𝗧-𝟱𝟴⁣ ligand, could signify a significant advancement in the research and enhancement of therapeutic approaches for 𝗶𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 through C5aR1.⁣ ⁣ 💥Click to read 📖 the article 👇⁣ ⁣ #C5aR1 #CELT58 #C5a, #inflamation #neuropsychiatric #cancer #fluorescenceprobes #celtarys #innovation

😀 Happy to share pix from the First Early Career Research Day organized by Institut de Biomedicina de la Universitat de Barcelona | IBUB that was held last friday at Aula Magna of the Faculty of Biology (UB). 👌 It was a fabulous success in terms of participation and the speakers presentations were of great scientific interest. Question sessions were dynamic, with a high participation of the attendees. 🥇 It was an honor to sponsor 2 awards! 👏 Congratulations to Noemi Villella from MCP - Medicinal Chemistry and Pharmacology and Núria Corbella Rius from Universitat de Barcelona for these well deserved awards for your work.

🙌 Congratulations to all the Bioga team for another great 2nd edition of the reference forum of biotechnology and life sciences industry in the European Atlantic Area! Part of our Celtarys Research team was enjoying the #GaliciaBiodays2024 beeing an ideal environment 🌐 for the biotech sector to establish contacts, synergies, networking and promote new collaboration ideas! 💡 Looking forward for future editions! 🤝 Wilson Gomes, Eddy Sotelo, Maria Majellaro, Sandra Ortigueira Noya #biotecnología, #innovación, #emprendimiento #talento #Galicia

📣We are thrilled to introduce you our new CEO, Wilson Gomes at Celtarys Research!⁣ 🎊 ⁣ Wilson Gomes brings over two decades in the medical technology industry. He has held executive roles at Johnson & Johnson and Danaher, focusing on Sales, Marketing, and General Management across the EMEA region. Wilson’s educational background includes a mechanical engineering degree, an MBA from the University of North Carolina, and the General Management Program from Harvard Business School.⁣ ⁣ His career is marked by a passion for disrupting traditional healthcare models and bringing innovative solutions to market.⁣ 🤝Join our scientific leader, Professor Eddy Sotelo and our CSO, María Majellaro in warmly welcoming to Wilson⁣: Eddy Sotelo “We are very pleased to welcome Wilson and excited to open a new chapter at Celtarys, taking on new challenges and advancing our strategic objectives”⁣ Maria Majellaro “We are very excited to welcome Wilson to our team! His experience, skills, attitude, and commitment perfectly align with Celtarys' vision and future expectations. I’m sure he will do a great job, driving our company forward and achieving our strategic goals!”⁣ ⁣ Wilson Gomes “I’m thrilled to join the Celtarys team. Celtarys is pioneering disruptive technology that accelerates and enhances the drug discovery process, making it faster, safer, and smarter. I’m looking forward to working with the talented Celtarys team to further develop our innovative pipeline and drive our vision forward”⁣ ⁣ 💥Please join us in welcoming Wilson to Celtarys and wishing him great success in this new role.⁣ W𝗲𝗹𝗰𝗼𝗺𝗲 𝗮𝗯𝗼𝗮𝗿𝗱! 🎉⁣ ⁣ 🌐 𝗖𝗼𝗻𝗻𝗲𝗰𝘁 with Wilson on 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:⁣ Wilson Gomes ⁣ ⁣#Leadership #NewCEO #celtarys #drugdiscovery #celtarysteam

💥 Our CSO Maria Majellaro will participate to the EFM-International Symposium on Medical Chemistry in Rome! 💫 She will take part in the "Early Career Woman in Medical Chemistry & Chemical Biology" sesion on next Septtember 4th. Congratulations, Maria Majellaro, for being part of this prestigious symposium! 👏 https://www.efmc-ismc.org/ #EFMCISMC2024 #MedicinalChemistry #ChemicalBiology #EarlyCareerWomen #Conference

📢The sigma receptors have gained attention as potential therapeutic targets for various 𝗻𝗲𝘂𝗿𝗼𝗱𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 and 𝗻𝗲𝘂𝗿𝗼𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁𝗮𝗹 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀 . ⁣ 👉 𝗦𝗶𝗴𝗺𝗮-𝟭 𝗮𝗻𝗱 𝗦𝗶𝗴𝗺𝗮-𝟮 receptor antagonists play crucial roles in 𝗻𝗲𝘂𝗿𝗼𝗽𝗿𝗼𝘁𝗲𝗰𝘁𝗶𝗼𝗻 and reducing Alzheimer’s disease pathology. Sigma-1 receptor activation 𝗲𝗻𝗵𝗮𝗻𝗰𝗲𝘀 𝗻𝗲𝘂𝗿𝗼𝗽𝗹𝗮𝘀𝘁𝗶𝗰𝗶𝘁𝘆 𝗮𝗻𝗱 𝗿𝗲𝗱𝘂𝗰𝗲𝘀 𝗻𝗲𝘂𝗿𝗼𝗶𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻, while Sigma-2 receptor antagonists 𝗽𝗿𝗲𝘃𝗲𝗻𝘁 Aβ oligomer-induced 𝗻𝗲𝘂𝗿𝗼𝘁𝗼𝘅𝗶𝗰𝗶𝘁𝘆 𝗮𝗻𝗱 𝘀𝘆𝗻𝗮𝗽𝘁𝗶𝗰 𝗱𝗮𝗺𝗮𝗴𝗲. 💥 🔆𝗖𝗘𝗟𝗧-𝟰𝟴𝟯 ligand as new alternatives for the study and improvement of therapeutic tools in neurodegenerative & neurodevelopmental disorders regulation via 𝗦𝗶𝗴𝗺𝗮-𝟭 𝗮𝗻𝗱 𝗦𝗶𝗴𝗺𝗮-𝟮 𝗿𝗲𝗰𝗲𝗽𝘁𝗼𝗿. 💥Click to read 📖 the article 👇 #CELT483, #Sigmareceptors, #neuroprotection, #neuroplasticity, #neurodegenerative, #alzheimer, #Huntington’s #Parkinson’s, #sclerosis, #neuroinflammatory

🔔 📣 Don´t miss the opportunity to go to the First Early Career Research Day organized by Institut de Biomedicina de la Universitat de Barcelona | IBUB that will be held on June 14th ,2024 at Aula Magna of the Faculty of Biology (UB). 📝 More info here: 👇 https://lnkd.in/d-EcMxmh